OnBioVC http://onbiovc.com Your Source for BioScience Venture Capital Data Wed, 04 Nov 2009 05:51:57 +0000 http://wordpress.org/?v=2.6.5 en noYour Source for BioScience Venture Capital DataOnbiovchttp://feedburner.google.com September 2009 OnBioVC | Trend Analysis Now Available http://feedproxy.google.com/~r/Onbiovc/~3/BJ5SCBFk6lk/ http://onbiovc.com/september-2009-onbiovc-trend-analysis-now-available/#comments Wed, 04 Nov 2009 05:47:41 +0000 arubenstein http://onbiovc.com/?p=1485 Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who you believe would likewise be interested in the content. Thank you!
________________________________________________________________________

Sign up [HERE] for FREE Subscription to ‘Pharmaceutical Executive’ and ‘Life Science Leader’ Magazines (and other journals too!)

]]> http://onbiovc.com/september-2009-onbiovc-trend-analysis-now-available/feed/ noHot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you Hot off the press! The September 2009 OnBioVC | Trend Analysis study is now available for download [HERE]. Over $465M flowed into early-stage biopharma, diagnostic and device companies in the ninth month of 2009 and over $4,806M year-to-date! If you find the information in OnBioVC to be of value kindly forward on to colleagues who [...]Uncategorizedhttp://onbiovc.com/september-2009-onbiovc-trend-analysis-now-available/ Celladon, Inc.: Series C $21.8M http://feedproxy.google.com/~r/Onbiovc/~3/Qobz3atL5oA/ http://onbiovc.com/celladon-inc-series-c-218m/#comments Mon, 02 Nov 2009 22:22:55 +0000 arubenstein http://onbiovc.com/?p=1480 Celladon (La Jolla, CA) a clinical-stage company focused on gene therapy for congestive heart failure, closed a $21.8M Series C financing. Participants include Enterprise Partners Venture Capital, Venrock and Johnson & Johnson Dev Corp.

]]> http://onbiovc.com/celladon-inc-series-c-218m/feed/ http://onbiovc.com/celladon-inc-series-c-218m/ Quanta Fluid Solutions, Ltd.: Series A $14.3M http://feedproxy.google.com/~r/Onbiovc/~3/bR0bLMIwj_Q/ http://onbiovc.com/quanta-fluid-solutions-ltd-series-a-143m/#comments Mon, 02 Nov 2009 21:47:24 +0000 arubenstein http://onbiovc.com/?p=1478 Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.

]]> http://onbiovc.com/quanta-fluid-solutions-ltd-series-a-143m/feed/ http://onbiovc.com/quanta-fluid-solutions-ltd-series-a-143m/ Calypso Medical Technologies, Inc.: Series E $50M http://feedproxy.google.com/~r/Onbiovc/~3/INzhuuwnjJg/ http://onbiovc.com/calypso-medical-technologies-inc-series-e-50m/#comments Mon, 02 Nov 2009 21:29:58 +0000 arubenstein http://onbiovc.com/?p=1475 Calypso Medical Technologies (Seattle, WA) a commercial-stage medical device company focused on implantable sensor electromagnetic transponders, to accurately and continuously pinpoint the location of tumors in real-time during radiation therapy delivery, closed a $50M Series E financing. Participants include Skyline Ventures, Frazier Healthcare Ventures, Bay City Capital and InterWest Partners.

]]> http://onbiovc.com/calypso-medical-technologies-inc-series-e-50m/feed/ http://onbiovc.com/calypso-medical-technologies-inc-series-e-50m/ NextBio, Inc.: Series C $8M http://feedproxy.google.com/~r/Onbiovc/~3/q2e2Oi_UVTs/ http://onbiovc.com/nextbio-inc-series-c-8m/#comments Mon, 02 Nov 2009 21:27:19 +0000 arubenstein http://onbiovc.com/?p=1473 NextBio (Cupertino, CA) a commercial-stage bioinformatics and competitive intelligence bioscience search engine, closed a $8M Series C financing. Participants include Newbury Ventures.

]]> http://onbiovc.com/nextbio-inc-series-c-8m/feed/ http://onbiovc.com/nextbio-inc-series-c-8m/ Seaside Therapeutics, LLC: Series A $30M http://feedproxy.google.com/~r/Onbiovc/~3/O90s0ZE4SSg/ http://onbiovc.com/seaside-therapeutics-llc-series-a-30m/#comments Mon, 02 Nov 2009 21:24:49 +0000 arubenstein http://onbiovc.com/?p=1471 Seaside Therapeutics (Cambridge, MA) a clinical-stage biopharmaceutical company focused on autism and Fragile X syndrome, closed a $30M Series A financing. Participants were not identified.

]]> http://onbiovc.com/seaside-therapeutics-llc-series-a-30m/feed/ http://onbiovc.com/seaside-therapeutics-llc-series-a-30m/ Juvaris BioTherapeutics, Inc.: Series B $12.5M* http://feedproxy.google.com/~r/Onbiovc/~3/IXazOJHUjQQ/ http://onbiovc.com/juvaris-biotherapeutics-inc-series-b-125m/#comments Mon, 02 Nov 2009 21:22:46 +0000 arubenstein http://onbiovc.com/?p=1469 Juvaris BioTherapeutics (Pleasanton, CA) a clinical-stage biopharma company focused on adjuvanted vaccines for seasonal flu and immunotherapeutics for Leukemia and animal health, closed a $12.5M Series B financing. Participants include SV Life Sciences and Kleiner Perkins Caufield & Byers.

*Estimated first close of round

]]> http://onbiovc.com/juvaris-biotherapeutics-inc-series-b-125m/feed/ http://onbiovc.com/juvaris-biotherapeutics-inc-series-b-125m/ PharmAbcine, Ltd.: Series A $6M http://feedproxy.google.com/~r/Onbiovc/~3/TpeuF1n1CQI/ http://onbiovc.com/pharmabcine-ltd-series-a-6m/#comments Mon, 02 Nov 2009 21:19:58 +0000 arubenstein http://onbiovc.com/?p=1467 PharmAbcine (South Korea) a development-stage biopharma company focused on the development of monoclonal antibodies for cancer and inflammatory disease, closed a $6M Series A financing. Participants include OrbiMed, Novartis Venture Fund, Green Cross, Tong Yang Venture Capital and Saehan Venture Fund.

]]> http://onbiovc.com/pharmabcine-ltd-series-a-6m/feed/ http://onbiovc.com/pharmabcine-ltd-series-a-6m/ Virtual Ports, Ltd.: Series A $2.6M http://feedproxy.google.com/~r/Onbiovc/~3/sotkTf8LoJg/ http://onbiovc.com/virtual-ports-ltd-series-a-26m/#comments Mon, 02 Nov 2009 21:15:05 +0000 arubenstein http://onbiovc.com/?p=1465 Virtual Ports (Israel) a commercial-stage medical device company focused on an internal retractor for laproscopic procedures and other endoscopic surgical tools, closed a $2.6M Series A financing. Participants include Virginia Life Science Investments and Skywalker Ventures.

]]> http://onbiovc.com/virtual-ports-ltd-series-a-26m/feed/ http://onbiovc.com/virtual-ports-ltd-series-a-26m/ Alvine Pharmaceuticals, Inc.: Series A $21.5M http://feedproxy.google.com/~r/Onbiovc/~3/k9OtmnQhT1E/ http://onbiovc.com/alvine-pharmaceuticals-inc-series-a-215m/#comments Mon, 02 Nov 2009 21:13:01 +0000 arubenstein http://onbiovc.com/?p=1463 Alvine Pharmaceuticals (San Carlos, CA) a clinical-stage biopharmaceutical company focused on autoimmune related GI disease such as Celiac disease, closed a $21.5M financing bringing the total round to $47.5M. Participants include Panorama Capital, InterWest Partners, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures.

]]> http://onbiovc.com/alvine-pharmaceuticals-inc-series-a-215m/feed/ http://onbiovc.com/alvine-pharmaceuticals-inc-series-a-215m/ nonadult